Clinical Trial Update: EBOla Post-Exposure Prophylaxis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating post-exposure prophylaxis for Ebola virus disease is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Ebola Virus Disease | Phase 3 | Status: NOT_YET_RECRUITING